OPKO buys Claro Diagnostics

Brian Dunham | | Health Imaging | Enterprise Imaging
Miami-based OPKO Health has acquired Woburn, Mass.-based Claro Diagnostics, a developer of a method to use microfluidics to perform up to 20 tests with a drop of blood.

The system consists of a disposable test cassette and a small desktop analyzer. Used together, the two perform blood tests and permit the transition of complex immunoassays to physicians’ offices, according to a release. The equipment can also be used for urology and infectious disease market applications, according to the company.

Financial details of the transaction were not disclosed.

Brian Dunham

Related Content

Do large language models help or hinder workflows related to radiology reports?
Telehealth visits not to blame for uptick in imaging orders, study shows
Up to half of medical organizations either already using or preparing to implement AI
Radiology practice's communication failure bears tragic consequences
Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.